keyword
Keywords lung, pulmonary, liver , hepat...

lung, pulmonary, liver , hepatic, metastases

https://read.qxmd.com/read/38572435/epithelioid-hemangioendothelioma-in-a-liver-transplant-recipient-a-case-report-of-an-extremely-rare-tumor
#1
JOURNAL ARTICLE
Margarida Gonçalves, Helena Pessegueiro, Judit Gandara, José Ramón Vizcaíno, Vitor Lopes, Sofia Ferreira
Epithelioid hemangioendothelioma is a very rare vascular neoplasm, which is often multifocal or metastatic at diagnosis. Most frequently arises in the liver, followed by the lung and bones. The authors present a case of a liver transplant recipient who developed a pattern of hepatic cholestasis associated with the appearance of a proliferative hepatic lesion with infiltrative growth. Histological examination and immunohistochemical study were compatible with the diagnosis of epithelioid hemangioendothelioma...
April 2024: GE Portuguese Journal of Gastroenterology
https://read.qxmd.com/read/38494820/-long-term-complete-response-by-capeox-plus-nivolumab-chemotherapy-for-postoperative-recurrence-of-gastric-cancer-a-case-report
#2
JOURNAL ARTICLE
Shinsuke Katsuyama, Toru Masuzawa, Keijiro Sugimura, Kiminori Yanagisawa, Go Shinke, Mitsuru Kinoshita, Ryo Ikeshima, Masayuki Hiraki, Yoshiaki Ohmura, Taishi Hata, Yutaka Takeda, Kohei Murata
A 73-year-old man underwent upper gastrointestinal endoscopy during a medical check-up that revealed a Type 2 lesion in the anterior wall of the gastric body. The biopsy confirmed tub2. A contrast-enhanced CT scan revealed focal wall thickening and lymphadenopathy in the gastric body. The patient was diagnosed with gastric cancer(M, ante, Type 2, T4aN1M0, Stage ⅢA). Laparotomy total gastrectomy D2 dissection and Roux-en-Y reconstruction were performed. Pathological results were tub1, int, INF b, ly0, v1, pT4aN0M0, pStage ⅡB...
March 2024: Gan to Kagaku Ryoho. Cancer & Chemotherapy
https://read.qxmd.com/read/38435446/pulmonary-metastasectomy-after-radiofrequency-ablation-of-hepatocellular-carcinoma
#3
Takahiro Osuga, Shingo Tanaka, Tomohiro Kubo, Kota Hamaguchi, Ryo Ito, Akira Sakurada, Keidai Ishikawa, Koji Miyanishi
INTRODUCTION: Single distant metastases after radiofrequency ablation (RFA) of hepatocellular carcinoma (HCC) are rare. There are no guidelines for treating patients without liver tumors after resecting lung metastases. CASE PRESENTATION: Here, we report a patient with HCC recurring as a single lung metastasis 14 months after RFA. A 76-year-old woman with primary biliary cholangitis without hepatitis B virus or hepatitis C virus infection had been treated by RFA for a single 16-mm-sized HCC lesion in liver S8...
2024: Case Reports in Oncology
https://read.qxmd.com/read/38303231/-a-case-of-long-term-survival-with-metachronous-hepatic-and-pulmonary-metastases-from-transverse-colon-cancer-by-multidisciplinary-treatment
#4
JOURNAL ARTICLE
Takeo Hara, Miho Okano, Tomoki Hata, Osamu Takayama, Yongkook Kim, Haruhiko Imamoto, Junichi Hasegawa
A 64-year-old woman underwent right hemicolectomy for transverse colon cancer. Histopathological findings revealed T, type 2, 24×22 mm, tub2, pT2N1a(1/23)M0, and pStage Ⅲa. Postoperative adjuvant chemotherapy was not administered at the patient's request. One year after surgery, carcinoembryonic antigen(CEA)level was elevated, and Gd-EOB-DTPA- enhanced MRI revealed a nodule in segment 2 and 4/8 of the liver. Based on the diagnosis of hepatic metastasis, laparoscopic partial hepatectomy was performed...
December 2023: Gan to Kagaku Ryoho. Cancer & Chemotherapy
https://read.qxmd.com/read/38178372/net-induced-carcinoid-heart-disease-affecting-both-tricuspid-and-aortic-valves-due-to-patent-foramen-ovale-and-right-left-shunt-a-multi-imaging-challenge-to-nuclear-medicine
#5
JOURNAL ARTICLE
Christina Laschinsky, Matthias Welsner, Amir A Mahabadi, Harald Lahner, Hubertus Hautzel
Carcinoid heart disease (Hedinger syndrome) is a long-term consequence in hormone-active neuroendocrine tumors with hepatic metastases and carcinoid syndrome. Because of serotonin, excess multiple cardiac and pulmonary symptoms evolve, which are further complicated by a patent foramen ovale due to right-left shunting. We present a 53-year-old man with an ileum-neuroendocrine tumor including gross liver metastases and long-term stable disease who subsequently developed Hedinger syndrome. Initially experiencing progressive dyspnea, he eventually experienced severe hypoxemia due to patent foramen ovale...
February 1, 2024: Clinical Nuclear Medicine
https://read.qxmd.com/read/37899904/a-rare-case-of-an-occult-primary-tumor-with-a-profile-of-colon-cancer-and-synchronous-metastasis-in-the-lung-liver-bone-and-cerebellum-a-case-report-and-literature-review
#6
Ramona Abrudan, Luca Abrudan, Ovidiu Pop, Dana Carmen Zaha
Occult primary tumors, or cancers of unknown primary site (CUP), are an oncological pathology characterized by the presence of metastases but without being able to determine the presence of the primary tumor. These types of tumors are very rare, and they pose challenges for diagnosis and treatment. Colorectal cancer is the most common type of malignant tumor worldwide and the second most common cause of death. The most common sites of metastasis in colorectal cancer are hepatic and pulmonary. Relatively rare, patients develop brain and bone metastasis...
October 2023: Curēus
https://read.qxmd.com/read/37701683/long-term-survival-of-patients-with-hepatocellular-carcinoma-with-hepatic-pulmonary-peritoneal-and-rare-colon-metastasis-a-case-report
#7
Yong-Qiang Gong, Tai-Liang Lu, Chao-Wu Chen
BACKGROUND: Hepatocellular carcinoma (HCC) is a highly malignant cancer that often metastasizes and has a poor prognosis. Gastrointestinal tract metastases are rare, and colon metastases are even rarer. The long-term survival of patients with multiple intrahepatic and extrahepatic metastases, especially to the colon, has not been previously reported. CASE SUMMARY: We present an atypical clinical case of a patient with liver, right lung, peritoneal, and colon metastases diagnosed successively following hepatic resection for primary HCC...
August 27, 2023: World Journal of Gastrointestinal Surgery
https://read.qxmd.com/read/37457601/a-rare-case-of-benign-metastasizing-leiomyoma-causing-t11-spinal-cord-compression-a-report-and-literature-review
#8
Gyuhee Seong, Simran Ahluwalia, Desiree Joy Anne Talabong, Burak Erdinc, Amena Mohiuddin, Maksim Agaronov, Edwin Chiu
Diagnosis of uterine smooth muscle tumors depends upon histologic characteristics as both benign and malignant share clinical features such as metastases. A benign metastasizing leiomyoma is a rare benign smooth muscle tumor that metastasizes to extrauterine sites with simultaneous uterine leiomyoma or previously biopsy-proven leiomyoma during myomectomy or hysterectomy. Benign metastasizing leiomyoma metastasizes outside the uterus, predominantly to the lungs and lymph nodes. However, the involvement of other organs, such as the heart, liver, spine, and soft tissue, is also reported...
July 2023: Curēus
https://read.qxmd.com/read/37251947/checkpoint-inhibitor-induced-gastritis-followed-by-delayed-severe-hepatitis-in-a-patient-with-lung-metastases-of-head-and-neck-squamous-cell-carcinoma-a-case-report
#9
Tomoyuki Otsuka, Yoshiko Hashii, Sei Murayama, Yasunobu Ishizuka, Yoshiki Kojitani, Minako Nishio, Toshihiro Kudo
Pembrolizumab, an anti-programmed death-1 (PD-1) receptor monoclonal antibody, is an effective first-line therapy for metastatic head and neck squamous cell carcinoma. Immune-related adverse events (irAEs) are well-described complications of PD-1 inhibitors, and multiorgan irAEs are known to occur occasionally. We report a patient with pulmonary metastases of oropharyngeal squamous cell carcinoma (SCC), who developed gastritis followed by delayed severe hepatitis and recovered with triple immunosuppressant therapy...
2023: Frontiers in Oncology
https://read.qxmd.com/read/37191837/a-case-of-neuroendocrine-carcinoma-with-massive-invasion-to-the-liver-and-multiorgan-causing-acute-liver-failure
#10
JOURNAL ARTICLE
Yuri Ogasawara, Naoko Ito, Tomomi Kogiso, Saeko Yoshizawa, Yoji Nagashima, Katsutoshi Tokushige
INTRODUCTION: Acute liver failure (ALF) due to a malignant neoplasm is rare. Here, we present a case of neuroendocrine carcinoma (NEC) with massive invasion to the liver and multi-organ causing ALF that resulted in a poor outcome. A 56-year-old man was referred to our hospital for ALF of unknown cause. Abdominal imaging studies revealed hepatomegaly with multiple intrahepatic lesions. The patient also showed disseminated intravascular coagulation. Despite administration of prednisolone for the ALF, he died suddenly of respiratory failure on day 3 after admission...
August 2023: Clinical Journal of Gastroenterology
https://read.qxmd.com/read/37182067/pulmonary-tumor-embolism-complicated-by-metastatic-liver-carcinoma-in-female-with-primary-breast-carcinoma
#11
Zanib Shahbaz, Pugazhendi Inban, Dev K Patel, Tass Sayeed, Baris Tarimci, Idowu O Adewole, Nabi Nadia, Prashant Obed R Dundi, Taha Sajjad, Aadil Khan
Pulmonary tumor embolism (PTE) is a rare phenomenon typically presenting as dyspnea in cancer patients. Primary pathophysiology is similar to the thromboembolic disease of the pulmonary vasculature, which involves large vessels to small arterioles. This phenomenon occurs mostly in lung, stomach, liver, and breast adenocarcinoma. The symptoms of hypoxemia and the signs of hemodynamic instability and high-resolution computed tomography (CT) scans, along with a histopathological examination, are essential to make a confirmatory diagnosis of pulmonary tumor embolism...
April 2023: Curēus
https://read.qxmd.com/read/37170545/digestive-pseuodpolyposis-as-a-form-of-presentation-of-digestive-metastases-of-primary-gastric-leiomyosarcoma
#12
JOURNAL ARTICLE
Olga Ortega Lobete, Alberto Pérez Garvin, Isabel Payeras Otero, Óscar Nogales Rincón
A 71-year-old male was diagnosed with gastric leiomyosarcoma in 2020 after biopsies of an ulcerated gastric lesion. Despite oncological treatment, he presented bone, liver and lung progression. Fourth line treatment with Pazopanib was started in 2022 with no evidence of intestinal or peritoneal metastases. He was attended in the Emergency Department in February 2023 due to symptoms of gastrointestinal bleeding with clinical and analytical repercussion with hemoglobin 5.8g/dl. Initially he presented hematemesis and subsequently hematochezia...
May 12, 2023: Revista Española de Enfermedades Digestivas
https://read.qxmd.com/read/36803208/is-lung-involvement-a-favorable-prognostic-factor-for-pancreatic-ductal-adenocarcinoma-with-synchronous-liver-metastases-a-propensity-score-analysis
#13
JOURNAL ARTICLE
Huaqiang Ouyang, Weidong Ma, Xiangli Jiang, Anna Sandström Gerdtsson, Donglin Liu, Zhanyu Pan
BACKGROUND: : For advanced pancreatic cancer, pulmonary metastases (PM) have been considered favorable factors compared to metastases of other sites, but it remains unknown whether the prognosis of patients with synchronous liver and lung metastases is better than that of non-PM. METHODS: Data was derived from a two-decade cohort and included 932 cases of pancreatic adenocarcinoma with synchronous liver metastases (PACLM). Propensity score matching (PSM) was applied to balance 360 selected cases, grouped into PM (n = 90) and non-PM (n = 270)...
February 20, 2023: Expert Review of Gastroenterology & Hepatology
https://read.qxmd.com/read/36716457/fdg-pet-ct-in-a-case-of-primary-angiosarcoma-of-the-kidney
#14
JOURNAL ARTICLE
Jian Yang, Aisheng Dong, Shensheng Nian, Yonghan Peng, Changjing Zuo
Primary angiosarcoma of the kidney is a rare aggressive malignancy. We describe MRI and FDG PET/CT findings in a case of primary renal angiosarcoma with hepatic, pulmonary, and bony metastases. The large primary tumor showed extensive necrosis and increased FDG uptake in the nonnecrotic components. Multiple metastatic lesions in the liver, lung, and bones were detected by FDG PET/CT. Most of the hepatic metastases seen on MRI were missed on FDG PET/CT due to low FDG avidity.
January 30, 2023: Clinical Nuclear Medicine
https://read.qxmd.com/read/36400583/prognostic-differences-between-oligometastatic-and-polymetastatic-disease-after-resection-in-patients-with-colorectal-cancer-and-hepatic-or-lung-metastases-retrospective-analysis-of-a-large-cohort-at-a-single-institution
#15
JOURNAL ARTICLE
Tomoko Horie, Yukihide Kanemitsu, Yasuyuki Takamizawa, Konosuke Moritani, Shunsuke Tsukamoto, Dai Shida
BACKGROUND: Long-term survival data are lacking, and prognostic factors are not well-defined for patients with colorectal cancer and hepatic or lung metastases. This study evaluated the outcomes after resection of oligometastatic hepatic or lung metastases from colorectal cancer and sought to identify prognostic factors. METHODS: We retrospectively investigated 1,123 patients with colorectal cancer and hepatic or pulmonary metastases who underwent curative surgery between January 1991 and December 2016...
November 15, 2022: Surgery
https://read.qxmd.com/read/35904571/pancreatic-metastases-after-surgery-for-renal-cell-carcinoma-survival-and-pathways-of-progression
#16
JOURNAL ARTICLE
Daniele Cignoli, Giuseppe Fallara, Francesca Aleotti, Alessandro Larcher, Giuseppe Rosiello, Isaline Rowe, Giuseppe Basile, Gianmarco Colandrea, Alberto Martini, Francesco De Cobelli, Giorgio Brembilla, Roberta Lucianò, Maurizio Colecchia, Marco Schiavo Lena, Stefano Partelli, Domenico Tamburrino, Giuseppe Zamboni, Corrado Rubini, Massimo Falconi, Francesco Montorsi, Andrea Salonia, Umberto Capitanio
PURPOSE: Metastatic ccRCC has peculiar tropism in the pancreas. We describe the characteristics and pathways of progression of patients with PM in a large multi-institutional consortium and compare them to patients with metastases from ccRCC at other sites. METHODS: Detailed clinical and histopathological data were collected. To account for differences in baseline characteristics between the two groups, IPTW was used to compare the two groups in terms of PFS and OS...
July 29, 2022: World Journal of Urology
https://read.qxmd.com/read/35876920/intervention-for-hepatic-and-pulmonary-metastases-in-breast-cancer-patients-prospective-multi-institutional-registry-study-imet-protocol-mf-14-02
#17
JOURNAL ARTICLE
Atilla Soran, S Ozbas, B Ozcinar, A Isik, L Dogan, K Senol, A Dag, H Karanlik, O Aytac, G Karadeniz Cakmak, K Dalci, M Dogan, Y A Sezer, S Gokgoz, E Ozyar, E Sezgin
BACKGROUND: One fourth of early-stage breast cancer cases become metastatic during the follow-up period. Limited metastasis is a metastatic disease condition in which the number of metastatic sites and the extent of the disease both are limited, and the disease is amenable to metastatic intervention. This prospective study aimed to evaluate intervention for limited metastases in the lung, liver, or both. METHODS: The study enrolled luminal A/B and/or human epidermal growth factor receptor 2 (HER2)-neu+ patients with operable lung and/or liver metastases in the follow-up assessment after completion of primary breast cancer treatment and patients with a diagnosis of metastasis after 2014...
October 2022: Annals of Surgical Oncology
https://read.qxmd.com/read/35781519/pleural-effusion-as-the-initial-presentation-of-gastric-adenocarcinoma-a-case-report
#18
JOURNAL ARTICLE
Conner V Lombardi, Logan D Glosser, Spiro Veria, Wade Hopper, Prabath Herath-Mudiyanselage
BACKGROUND Gastric adenocarcinoma is a common malignancy, representing the third most common cause of cancer-related death globally. Most patients are initially asymptomatic, but as the cancer progresses, patients typically present with vague gastrointestinal complaints, including early satiety, heart burn, vomiting, or abdominal pain. Metastatic gastric cancer is relatively uncommon, with ~26% of patients having metastasis to a single site and 13% having metastases to multiple sites. The most common site of metastasis is the liver, followed by peritoneum, lung, and bone...
July 4, 2022: American Journal of Case Reports
https://read.qxmd.com/read/35663055/hepatopulmonary-metastases-from-papillary-thyroid-microcarcinoma-a-case-report
#19
Chuan-Yu Yang, Xuan-Wu Chen, Dong Tang, Wen-Jun Yang, Xiao-Xiao Mi, Jun-Ping Shi, Wei-Dong Du
BACKGROUND: Papillary thyroid carcinoma (PTC) is the most common endocrine malignancy. Papillary thyroid microcarcinoma (PTMC) accounts for the majority of PTC cases. However, concurrent pulmonary and hepatic metastases of PTMC are rarely seen. Here, we present a patient with coexisting liver and lung metastases from PTMC. CASE SUMMARY: We describe a 26-year-old woman with PTMC with multiple concurrent metastases. After 3 d of unexplained fever, she was admitted to our hospital...
May 16, 2022: World Journal of Clinical Cases
https://read.qxmd.com/read/35613900/-a-case-of-metastatic-urothelial-carcinoma-with-pseudoprogression-of-liver-metastasis-during-the-treatment-with-pembrolizumab
#20
JOURNAL ARTICLE
Hiroo Masuda, Minoru Kato, Hiroki Yoshiuchi, Nao Yukimatsu, Yukiyoshi Hirayama, Taiyo Otoshi, Takeshi Yamasaki, Katsuyuki Kuratsukuri, Junji Uchida
A 75-year-old woman with a complaint of gross hematuria was referred to our hospital. The patient was diagnosed as having bladder cancer (cT3bN1M0) and received two cycles of chemotherapy with gemcitabine and cisplatin. Radical cystectomy with pelvic lymph node dissection and bilateral ureterostomy was performed after achieving partial response in a lymph node metastasis following chemotherapy. Based on the pathological diagnosis of high-grade (G3) urothelial carcinoma (ypT3aN2), two more cycles of adjuvant chemotherapy with gemcitabine and cisplatin were administered...
April 2022: Hinyokika Kiyo. Acta Urologica Japonica
keyword
keyword
27910
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.